Meeting
2020 Gastrointestinal Cancers Symposium
Gene polymorphisms of CCL3, CCL4, CCL5, and CCR5 network in metastatic colorectal cancer patients treated with regorafenib.
Authors
Mitsukuni Suenaga
Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
Mitsukuni Suenaga , Wu Zhang , Tetsuo Mashima , Marta Schirripa , Shu Cao , Satoshi Okazaki , Martin D. Berger , Yuji Miyamoto , Afsaneh Barzi , Heinz-Josef Lenz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 199)
Abstract #
199
Poster Bd #
J19
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Role of genetic polymorphisms in CCL5/CCR5 axis to predict efficacy of regorafenib in patients with refractory metastatic colorectal cancer.
First Author: Mitsukuni Suenaga
Poster
2017 ASCO Annual Meeting
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels to predict efficacy of bevacizumab in metastatic colorectal cancer patients receiving first-line chemotherapy.
First Author: Mitsukuni Suenaga
Poster
2017 ASCO Annual Meeting
Genetic polymorphisms of CCL5 and CCR5 to predict efficacy of cetuximab-based treatment in metastatic colorectal cancer patients depending on primary tumor location.
First Author: Mitsukuni Suenaga
Poster
2021 Gastrointestinal Cancers Symposium
Single nucleotide polymorphisms (SNPs) in endoplasmic reticulum (ER) stress response genes to predict first-line treatment outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from the MAVERICC and FIRE-3 trials.
First Author: Francesca Battaglin